Clinical trial for the prevention of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 12 May 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary) ; Pitavastatin (Primary) ; Tocopherol acetate (Primary)
Indications Osteonecrosis
Focus Therapeutic Use

24 Sep 2014 Actual initiation date changed from 1 Oct 2012 to 1 Aug 2014, according to University Hospital Medical Information Network - Japan record.
24 Sep 2014 The dose of pitavastatin calcium has been changed from 4mg/day to 2 mg/day, according to University Hospital Medical Information Network - Japan record.
24 Sep 2014 Planned End Date changed from 1 Oct 2015 to 1 Aug 2016, according to University Hospital Medical Information Network - Japan record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com